Oxytocin vs Vasopressin
Updated October 16, 2026 · Reviewed by the PeptidesDB Editorial team
A data-driven comparison of Oxytocin and Vasopressin (also searched as Vasopressin vs Oxytocin) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.
Verdict
Oxytocin centers on neuro, while Vasopressin leans toward neuro. On indexed research, Oxytocin is ahead (Oxytocin: 40 studies, Human clinical; Vasopressin: 35, Human clinical). Choose by goal — and read the primary studies. This is research information, not medical advice.
Key takeaways
- •Oxytocin is strongest for neuro; Vasopressin for neuro.
- •Evidence: Oxytocin Human clinical (40 studies) vs Vasopressin Human clinical (35).
- •Check the FDA-approval status chips above before assuming a legal use pathway.
Effect profiles, overlaid
At a glance
Neuropeptide | Social bonding and emotional regulation
Vasopressor | Diabetes insipidus treatment
Oxytocin vs Vasopressin: side-by-side
| Metric | Oxytocin | Vasopressin |
|---|---|---|
| Class | Neuro | Neuro |
| Regulatory status | FDA-approved | FDA-approved |
| Evidence grade | Human clinical | Human clinical |
| Studies indexed | 40 | 35 |
| Research level | FDA Approved | FDA Approved |
| Strongest effect | Neuro & mood | Neuro & mood |
| Healing & recovery | 2.0▲ | 2.0▲ |
| Muscle & body comp | 1.0▲ | 1.0▲ |
| Metabolic & appetite | 1.0 | 3.0▲ |
| Neuro & mood | 5.0▲ | 4.0 |
| Sleep & circadian | 2.0▲ | 2.0▲ |
| Inflammation & immune | 1.0▲ | 1.0▲ |
| Skin & aesthetics | 1.0▲ | 0.0 |
▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).
Mechanism & pharmacokinetics
| Property | Oxytocin | Vasopressin |
|---|---|---|
| Mechanism | Oxytocin receptor agonist | Vasopressin receptor agonist (V1a, V1b, V2) |
| Route | Intravenous injection; Intranasal administration | Subcutaneous injection |
| Half-life | ~3-5 min | ~10–20 min |
| Time to peak | ~30 min | ~30 min |
| Duration of action | 1-2 hours | ~2-8 hours |
Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.
What is Oxytocin?
Oxytocin is a neuropeptide synthesized in the hypothalamus and released by the posterior pituitary gland. It plays a significant role in various physiological and behavioral processes, including social bonding, reproductive behaviors, emotional regulation, childbirth, and lactation. The mechanisms of action of oxytocin involve its binding to specific receptors in the brain and peripheral tissues, influencing neural circuits associated with social cognition, attachment, and stress response.
Full Oxytocin profile, mechanism & studies →What is Vasopressin?
Research peptide discovered via AI researcher. peptide-based therapeutic
Full Vasopressin profile, mechanism & studies →Which is better for your goal?
| Goal | Better fit | Why |
|---|---|---|
| Healing | Even | Both ~2.0/5 |
| Muscle | Even | Both ~1.0/5 |
| Metabolic | Vasopressin | 3.0/5 effect signal |
| Neuro | Oxytocin | 5.0/5 effect signal |
| Sleep | Even | Both ~2.0/5 |
| Inflammation | Even | Both ~1.0/5 |
| Skin | Oxytocin | 1.0/5 effect signal |
Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.
Can you stack Oxytocin and Vasopressin?
People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because at least one is a research-use compound, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.
Oxytocin vs Vasopressin: side effects
No community-reported effects logged yet.
No community-reported effects logged yet.
Anonymous community reports (count = number of reports), not clinical incidence rates.
What the research says
Oxytocin has 40 approved studies indexed (Human clinical), and Vasopressin has 35 (Human clinical). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.
Frequently asked questions
Is Oxytocin or Vasopressin better?
It depends on your goal. Oxytocin is strongest for neuro; Vasopressin for neuro. Oxytocin has more indexed studies (40). See the goal-by-goal breakdown above.
Is Oxytocin or Vasopressin better for weight loss?
Vasopressin shows the stronger metabolic & appetite profile (3.0/5) in the AI-assigned effect profile — though weight-loss outcomes depend on the individual and the evidence base.
Is Oxytocin or Vasopressin better for muscle?
Both land close on the muscle & body-composition axis.
Which has more research, Oxytocin or Vasopressin?
Oxytocin has 40 approved studies indexed (Human clinical); Vasopressin has 35 (Human clinical). Higher counts mean more to read, not proven superiority.
Can you stack Oxytocin and Vasopressin?
Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.
What are the side effects of Oxytocin vs Vasopressin?
Oxytocin: no community-reported effects logged yet. Vasopressin: none logged yet. These are anonymous reports, not incidence rates — see each profile.
Is Oxytocin or Vasopressin FDA-approved?
Oxytocin is FDA-approved. Vasopressin is FDA-approved. Research-use status is not a legal clearance to compound or use in humans.
Is Vasopressin better than Oxytocin?
For neuro, Vasopressin has the edge; for neuro, Oxytocin does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.
Comparing related peptides
Regulatory & legal status
Approval status varies (see the chips at the top). FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed October 16, 2026.